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Mucosal associated invariant T (MAIT) cells recognise conserved microbial metabolites from
riboﬂavin synthesis. Striking evolutionary conservation and pulmonary abundance implicate
them in antibacterial host defence, yet their functions in protection against clinically
important pathogens are unknown. Here we show that mouse Legionella longbeachae infection
induces MR1-dependent MAIT cell activation and rapid pulmonary accumulation of
MAIT cells associated with immune protection detectable in immunocompetent host ani-
mals. MAIT cell protection is more evident in mice lacking CD4+ cells, and adoptive transfer
of MAIT cells rescues immunodeﬁcient Rag2−/−γC−/− mice from lethal Legionella infection.
Protection is dependent on MR1, IFN-γ and GM-CSF, but not IL-17A, TNF or perforin, and
enhanced protection is detected earlier after infection of mice antigen-primed to boost MAIT
cell numbers before infection. Our ﬁndings deﬁne a function for MAIT cells in protection
against a major human pathogen and indicate a potential role for vaccination to enhance
MAIT cell immunity.
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Mucosal associated invariant T (MAIT) cells are innate-like lymphocytes with the potential to recognise a broadrange of microbial pathogens. MAIT cells express a
‘semi-invariant’ αβ T-cell receptor (TCR) and recognise small
molecule antigens presented by the major histocompatibility
complex (MHC) class I-related molecule (MR1)1,2. These anti-
gens comprise derivatives of the riboﬂavin biosynthetic path-
way3–5, which is conserved between a wide variety of bacteria,
mycobacteria and yeasts3,6, but is absent from mammals, and
therefore provides an elegant mechanism to discriminate host
and pathogen. Indeed, the enzymatic pathway required for
riboﬂavin synthesis has been identiﬁed in all microbes shown to
activate MAIT cells, and is absent in those that do not3.
A striking feature of MAIT cell immunity is the high level of
conservation of MR1 across 150 million years of mammalian
evolution7–9, implying a strong evolutionary pressure to maintain
the MAIT cell compartment. Furthermore, MAIT cells have a
strong pro-inﬂammatory phenotype10 and are abundant in
humans in blood and lung tissue11, whilst in C57BL/6 mice they
are found in greater abundance in the lungs than any other
organ12. Together, these features implicate MAIT cells in a critical
role in respiratory host defence. However, very few pathogens
have been demonstrated in vivo to cause activation and pro-
liferation of MAIT cells13,14. In studies implicating a role for
MAIT cells in protective immunity against pathogens, the deﬁ-
nition of these cells was limited by the lack of MR1-Ag tetra-
mers14. To date, no studies have clearly deﬁned a functional role
for MAIT cells in protection against a clinically important human
pathogen.
Using a model of bacterial lung infection with the intracellular
bacteria Salmonella enterica serovar Typhimurium we have pre-
viously shown that riboﬂavin gene-competent bacteria can cause
rapid activation and proliferation of MAIT cells13. We therefore
hypothesised that this response could also be elicited with an
authentic human lung pathogen and would contribute to pro-
tection against disease.
Legionella spp. are facultative intracellular pathogens, Gram-
negative, ﬂagellated bacteria which, when inhaled, cause a spec-
trum of disease from self-limiting Pontiac fever to severe, necrotic
pneumonia: Legionnaires’ disease15. The incidence of Legion-
naires’ disease has nearly trebled since 2000, with >5000 cases per
year in the United States, inﬂicting a 10% mortality despite best
treatment16. In North America and Europe16 the predominant
pathogen is L. pneumophila whereas in Australasia and Thailand
more than 50% of cases are caused by L. longbeachae17.
Here we use MR1 tetramers loaded with the potent MAIT cell
ligand 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-
OP-RU)18 to identify4 and characterise MAIT cells in human
in vitro and mouse in vivo models of lung infection with the two
most clinically signiﬁcant Legionella species: L. pneumophila and
L. longbeachae. Our data show that MAIT cells contribute to
protection against fatal infection with Legionella, by a mechanism
that is dependent on MR1, interferon-γ (IFN-γ) and granulocyte
macrophage-colony stimulating factor (GM-CSF). Protection is
partial in immunocompetent hosts but becomes increasingly
evident as other arms of immunity are disabled such as in CD4 T
cell-deﬁcient animals. Protection ultimately becomes 'all or
nothing' in profoundly immunodeﬁcient mice RAG2−/−γC−/−
mice. These studies dissect the mechanisms by which MAIT cells
contribute to protection against an important human disease and
a model intracellular pathogen.
Results
Legionella activate human MAIT cells in vitro via MR1. We3,13
have previously shown that MAIT cells are activated by microbial
species that express the riboﬂavin biosynthetic pathway; a ﬁnding
which has been conﬁrmed by others6. We therefore investigated
whether Legionella species—L. pneumophila15,19 and L. long-
beachae17—known to cause serious pulmonary infections in
humans and to express the necessary rib enzymes20, could acti-
vate human MAIT cells. First, bacterial lysates of L. pneumophila
and L. longbeachae stimulated a reporter cell line expressing a
MAIT TCR (Jurkat.MAIT-A-F7)3 in the presence of an MR1-
expressing lymphoid cell line (C1R.MR1) (Fig. 1a, for gating
strategy see Supplementary Fig. 1). Jurkat.MAIT cell activation
was dose dependent, and could be speciﬁcally blocked by anti-
MR1 antibody21. Next, we used a well-characterised human
monocytic cell line (THP1.MR1)22 as an antigen-presenting cell
co-cultured with human peripheral blood mononuclear cells
(PBMCs). We observed activation of MAIT cells when co-
cultured with THP1 cells infected for 27 h with live L. long-
beachae but not the co-cultured non-MAIT cells (Fig. 1b, c,
Supplementary Fig. 2). Intracellular infection of wild-type THP1
and THP1.MR1+ cell lines induced expression of tumor necrosis
factor (TNF) by human MR1-5-OP-RU tetramer+ MAIT cells.
Activation was related to the infective dose, and was speciﬁc to
MAIT cells and not non-MAIT CD3+ T cells. Activation was
MR1 dependent, as it did not occur in the presence of cells in
which we had disrupted the MR1 gene using a CRISPR/Cas9
lentiviral system (THP1.MR1−). MAIT cells also expressed IFN-
γ in the presence of MR1-overexpressing cells (THP1.MR1+), but
expression was less pronounced than TNF.
To visualise MAIT cells within their structural context in situ,
we infected healthy human lung tissue ex vivo with L.
longbeachae and observed CD3+ TCRVα7.2+ MAIT cells within
the lung parenchyma in the proximity of free and intracellular
Legionella bacilli 24 h post infection using immunoﬂuorescence
microscopy (Fig. 1d).
These ﬁndings indicate that Legionella induces signiﬁcant
MAIT cell immune responses in vitro and that MAIT cells are
present at the site of infection in the vicinity of immune cells
containing intracellular Legionella bacilli, suggesting that
MAIT cells are likely to play a role in protection against
Legionella pneumonia.
Legionella Ag activates mouse MAIT cells in vitro. Next we
examined murine MAIT cell activation in vitro by Legionella
using Vα19i Tg mice which have very high MAIT cell fre-
quencies. We used a bone marrow-derived macrophage cell line
transduced with the mouse MR1 gene (denoted as iBMDM.MR1)
as antigen-presenting cells. As expected, we observed upregula-
tion of the activation marker CD69 on transgenic splenic
MAIT cells upon adding Legionella lysate. This activation was
antigen-dose-dependent and partially MR1-dependent, being
partially blocked by anti-MR1 antibody 8F2 but not isotype
control (Fig. 2a). Interestingly, whilst anti-MR1 antibody com-
pletely blocked MAIT cell activation by the potent synthetic
ligand 5-OP-RU, blockade of activation by lysate was incomplete,
suggesting the lysate may contain some non-speciﬁc activating
elements (e.g., Toll-like receptor (TLR) agonists) yet to be
identiﬁed.
To visualise murine MAIT cells within their physiological
context in situ we infected wild-type C57BL/6 (MAIT sufﬁcient)
and MR1−/− (MAIT deﬁcient) mice with L. longbeachae and
observed MR1-5-OP-RU tetramer+, TCRβ+ MAIT cells within
the lung parenchyma of C57BL/6 mice (Fig. 2b), constituting the
ﬁrst demonstration of immunoﬂuorescent staining of MAIT cells
with murine MR1 tetramers. Importantly similar images were not
observed in negative controls using the same tissue stained with
non-speciﬁc control MR1-6-FP tetramer (Supplementary Fig. 3,
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row 4) or infected MR1−/− mice (row 2). The low frequencies of
MAIT cells in naive mice precluded similar co-stained cell images
(row 1).
In light of the close parallels between in vitro human and
murine MAIT cell studies, we undertook to investigate MAIT cell
responses in mice in vivo.
MAIT cells accumulate in lungs during Legionella infection.
Initially, we examined the impact of Legionella infection on
MAIT cells (deﬁned as CD45+TCRβ+ MR1-5-OP-RU tetramer-
positive cells) in vivo in a murine model using intranasal (i.n.)
infection with live L. longbeachae in immunocompetent mice. A
small (0.4–2%) but distinct MAIT cell population can be seen in
naive C57BL/6 mice (Fig. 3a, far left, for gating strategy see
Supplementary Fig. 4). There was striking accumulation of pul-
monary MAIT cells which comprised up to 30% of all pulmonary
αβ-T cells after 7 days of infection (Fig. 3a–e). MAIT cell
accumulation was dependent on the initial infecting inoculum
(Fig. 3a–c). The absolute number of MAIT cells increased up to
580-fold when infected with 105 colony-forming units (CFU) (P
< 0.0001, analysis of variance (one way-ANOVA) on log-
transformed data with post hoc Dunnett’s) L. longbeachae,
compared with the much less dramatic increase in conventional
αβ-T cells (maximum 9.4-fold, Dunnett’s test P < 0.0001)
(Fig. 3c). Accumulation occurred rapidly over 7 days post
infection (DPI), with absolute numbers peaking around day 10
(Fig. 3d). Furthermore, despite a subsequent 20-fold contraction
from peak frequencies (P= 0.005, Bonferroni-corrected t-test on
log-transformed data), overall expansion of the MAIT cell
population was long-lived, persisting for >280 DPI (Fig. 3d, e).
Interestingly, although MAIT cells have been implicated in
recruitment of non-MAIT T cells in a model of Francisella
tularensis infection14, we did not observe any signiﬁcant differ-
ence in pulmonary recruitment of αβ-T cells in MR1−/− mice,
which have an absolute deﬁciency of MAIT cells12,13.
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Fig. 1 Human MAIT cells are activated by Legionella infection via MR1 in vitro. a Jurkat.MAIT and C1R.MR1 cells were co-incubated for 16 h with lysates of L.
pneumophila (L. pn.) or L. longbeachae or 5-OP-RU, acetyl-6-formylpterin (Ac-6-FP) or PBS. Activation, detected by staining with anti-CD69, is enhanced by
bacterial lysate or by the activating ligand 5-OP-RU, but not by acetyl-6-FP. Activation was blocked by anti-MR1 antibody (26.5) but not by isotype control
(W6/32) 2 h prior to co-incubation. Experiment performed in triplicate wells on two separate occasions with similar results. Data show mean ﬂuorescence
intensity, MFI (±SEM). Statistical tests: one-way ANOVA and post hoc Dunnett’s comparing all columns with the ﬁrst column (black). Unpaired t-test
(blue), with ***P < 0.001; ****P < 0.0001. b, c THP1 cells (WT) or THP1 cells overexpressing MR1 (THP1.MR1+, purple) or deﬁcient in expression of MR1
(THP1.MR1−, blue) were infected for 27 h with live or heat-killed (HK) L. longbeachae (MOI: 100) or 10 nM 5-OP-RU, then co-cultured for 16 h with sorted
CD3+Vα7.2+CD161+ human peripheral blood MAIT cells, or MAIT-depleted conventional T cells. MR1-5-OP-RU-tetramer+ MAIT cell activation was
measured by intracellular cytokine staining for b TNF or c IFN-γ. b, c Percentage cytokine-positive cells as mean (±SEM) data from three independent
donors performed on two separate occasions are shown. Statistical tests: unpaired t-tests with Bonferroni corrections, each comparing against MOI 0 for
the speciﬁc cell line. Statistics with *P < 0.05; **P < 0.01. d Immunoﬂuorescence micrographs showing CD3+TCRVα7.2+ MAIT cell (white arrow) within
healthy human lung tissue (top panel) and 24 h post infection (bottom panels) ex vivo with L. longbeachae. Yellow arrow: intracellular L. longbechae bacilli.
Red, TCRVα7.2; green, CD3; magenta, polyclonal rabbit anti-L. longbeachae; blue, nuclei (Hoechst)
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Like L. longbeachae, i.n. infection with 2 × 107 CFU L.
pneumophila similarly induced a rapid expansion of MAIT cells
(Supplementary Fig. 5), although more modest than L. long-
beachae. As C57BL/6 mice are susceptible to L. longbeachae17, L.
longbeachae was selected as the most appropriate model for more
detailed investigation.
Histology of lungs from mice infected with 2 × 104 CFU of L.
longbeachae at 7 DPI demonstrated pronounced alveolar
inﬁltration of neutrophils and macrophages, leukocytoclasia,
aggregates of ﬁbrin and accumulation of oedema ﬂuid and
epithelial shedding, consistent with the typical features of human
L. pneumophila pneumonia15 (Supplementary Fig. 6A, C). These
inﬂammatory features were not observed in the uninfected mice
(Supplementary Fig. 6B, D). Blinded analysis of these sections
using a qualitative histological score at multiple time points post
infection revealed inﬂammation peaked at day 7, but there were
no gross histological differences in the severity of pneumonia
between C57BL/6 and MR1−/− mice (Supplementary Fig. 6E). To
determine the cellular localisation of L. longbeachae we measured
bacterial burden in ﬂow-sorted cells from collagenase-dispersed
murine lungs 3 days post infection. Most viable bacilli localised
within neutrophils, but evidence of infection of macrophages and
dendritic cells was also observed (Supplementary Fig. 6F).
A number of clinical studies have reported decreases in
peripheral blood MAIT cell frequencies associated with pulmon-
ary infections23–26, potentially attributable to recruitment from
the blood. To address the question as to the source of MAIT cells
at infection sites we used BrdU (5-bromo-2'-deoxyuridine)
incorporation assay, which enables quantitation of DNA synth-
esis, reﬂecting cell proliferation. As expected, only a few BrdU+
MAIT cells (approximately 1%) and conventional T cells (about
1.3%) were enumerated in naive mice (Fig. 3f, far left, Fig. 3g)
from both the lung and the draining mediastinal lymph nodes
(dLNs). These low percentages represent the minimum back-
ground staining, and basal rates of self-renewal of pre-existing
tissue resident memory cells27. As early as 3 DPI, an increased
proportion of BrdU+ MAIT cells could be detected (lung, 4.8%
and dLN, 2.4%) (Fig. 3f, g). On day 5 post infection, we detected a
signiﬁcant proportion of BrdU+ MAIT cells in both lung (26%)
and dLN (48%) (Fig. 3f, g). Interestingly, the higher proportions
of BrdU+ MAIT cells detected in the lungs compared with the
dLNs at 3 DPI were reversed at 5 DPI (Fig. 3f, g). An equivalent
change in these ratios was not observed among conventional
T cells. This could indicate earlier activation and proliferation of
MAIT cells locally in the lung tissue than in the dLN. Indeed, this
is consistent with our previous work in which MAIT cell
activation was detected as early as 2 h after antigen encounter,
indicating lung MAIT cells could be activated without being
primed in the draining LN13. Taken together, these data suggest
that MAIT cells proliferate locally—both in the tissue and the
dLN—upon infection. Furthermore, they suggest pulmonary
MAIT cell proliferation commences earlier than in the dLN,
consistent with the notion that conventional T-cell activation in
the dLN requires additional time for the antigen-loaded dendritic
cells to migrate to the dLN. The kinetics of conventional T cells
were consistent with previous reports28–31. It is well recognised
that naive T cells need 3–4 days before they are observed
proliferating in the dLN and are observed a day later at the site of
inﬂammation28.
To explore MAIT cell function we investigated the dynamics of
their cytokine proﬁle throughout infection. During acute L.
longbeachae infection, MAIT cells secreted interleukin (IL)-17A,
IFN-γ and GM-CSF (Fig. 4a, Supplementary Fig. 7A, B). The
percentage of IL-17A-expressing MAIT cells was high and
increased slightly throughout the course of infection (naive
22%, 7 DPI 27% and >100 DPI 30%; Fig. 4b, left panel), whilst
IFN-γ secretion was proportionately less, but nevertheless was
signiﬁcantly higher during the acute infection than in cells from
uninfected mice or after resolution (ANOVA with post hoc
Tukey’s test P= 0.03 and 0.0004 respectively, Fig. 4b, middle
panel). Conversely, the percentage of GM-CSF-expressing
MAIT cells was lowest during acute infection and peaked after
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disease resolution (P= 0.0004 acute vs resolution, t-test).
Absolute numbers of IL-17A-expressing MAIT cells increased
200-fold from baseline in acute infection and remained 27-fold
increased even after resolution of infection (Fig. 4c, left panel).
The greatest differences observed were in IFN-γ-secreting
MAIT cells, which increased 300-fold in acute infection,
contracting during resolution to 12-fold above baseline (Fig. 4c,
middle panel). Numbers of GM-CSF-secreting MAIT cells were
increased 89- and 41-fold during acute infection and resolution
(Fig. 4c, right panel). No changes were observed with isotype
(Supplementary Fig. 8A, B).
These cytokine expression proﬁles correlated closely with shifts
in expression of nuclear transcription factors associated with T
helper type 1 or 17 (Th1 or Th17) differentiation. In uninfected
mice most (81 ± 4%, mean ± SD) MAIT cells expressed the
orphan nuclear receptor, retinoic acid–related orphan receptor γt
(RORγt) alone: a master regulator of Th17 cell differentiation
(Fig. 4d, e, Supplementary Fig. 7C, D), but were negative for T-
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bet. Isotype controls are shown in Supplementary Fig. 8C. A
minority (13 ± 4%) of cells expressed both RORγt and the Th1
regulator T-bet, and very few expressed T-bet alone. However,
during acute infection and long-term post infection there was a
marked shift in phenotype towards predominant co-expression of
RORγt and T-bet in 64 ± 5% and 69 ± 3% of MAIT cells,
respectively. MAIT cells expressing T-bet alone were only
observed at signiﬁcant frequencies (14 ± 3%) in acute infection.
Thus, the consistent secretion of IL-17A in all stages of infection
and the transient increase of IFN-γ secretion during acute
infection reﬂect the changes in transcription factor proﬁle we
observed, suggesting the formation of an authentic memory pool
of MAIT cells and pointing to a speciﬁc role for IFN-γ in the
acute response to infection.
MAIT cell protection against life-threatening Legionella
infection is enhanced and accelerated by prior boosting. To
determine whether MAIT cells contribute to immune protection
against Legionella we compared the bacterial burden in lungs of
C57BL/6 and MR1−/− mice throughout infection. Bacterial load
increased by 2.5 log over the initial inoculum, peaking at 3 DPI.
In wild type versus MR1−/− on a C57BL/6 background we
observed a signiﬁcant difference in bacterial load, but not until
days 10 and 14 post infection, immediately subsequent to the time
of peak MAIT cell numbers at 7–9 DPI. Differences in bacterial
load were of the order of one log in CFU, consistent with
relatively impaired bacterial clearance in MAIT cell-deﬁcient,
MR1−/− mice (Fig. 5a, b).
In speciﬁc pathogen-free C57BL/6 mice, baseline frequencies of
MAIT cells are very low12,13, potentially due to a lack of natural
exposure to diverse environmental pathogens. We have pre-
viously shown that MAIT cells can be expanded in vivo by
intranasal exposure to the MAIT cell ligand 5-OP-RU with a TLR
agonist such as the TLR9 agonist CpG or TLR2 agonist S-[2,3-bis
(palmitoyloxy)propyl] cysteine (Pam2Cys) to furnish a MAIT cell
costimulus13. To understand whether MAIT cell vaccination
might impact on protection observed against Legionella infection
of the lung, we used this approach to speciﬁcally expand
pulmonary MAIT cells 1 month prior to Legionella infection,
without affecting conventional T-cell frequencies (Fig. 5c, d).
Prior exposure to 5-OP-RU and CpG enhanced MAIT cell
numbers in the lungs and was associated with protection against
infection as reﬂected in a reduction in bacterial load in C57BL/6
versus MR1−/− mice (Fig. 5e). This protective effect became
apparent earlier than observed in wild-type C57BL/6 mice with
reduced CFU seen on days 5 and 7 post infection and comparable
on day 10 post infection (compare Fig. 5a, b). When a direct
comparison was made between MR1−/− mice, C57BL/6 mice and
C57BL/6 mice that had been boosted by 5-OP-RU and Pam2Lys,
the bacterial burden was signiﬁcantly lower on days 5, 7 and 10
post infection in wild-type mice that had received prior MAIT cell
boosting (Fig. 5f). This demonstrates the potential to augment
MAIT cell-mediated protection by the prior administration of
synthetic ligands as a ‘vaccine’.
Studies of other intracellular pathogens have demonstrated
high levels of functional redundancy in the ability of different
lymphocyte subsets to control bacterial growth in vivo32. We
hypothesised that by removing partially redundant effects of
other lymphocyte subsets, the protective effects of MAIT cells
would become more apparent. CD4+ T cell-derived IFN-γ has
been shown to play an essential role in achieving bacterial
clearance of Salmonella Typhimurium32. We therefore used
GK1.5 transgenic mice, which express an anti-CD4 antibody and
are CD4+ T-cell deﬁcient33, and compared these with GK1.5.
MR1−/− mice which lack both CD4+ cells and MAIT cells. As
expected, we observed a protective effect of MAIT cells through
reduced bacterial burden apparent even earlier in the course of
infection than with wild-type mice (statistically signiﬁcant by 7
DPI) (Fig. 5g).
Collectively, these data demonstrate that MAIT cells contribute
signiﬁcantly to Legionella protection in the context of an intact
immune system and that this protection is more rapid and of
greater magnitude when mice are ﬁrst vaccinated to expand
MAIT cells before infectious challenge. Furthermore, the data
from GK1.5Tg and GK1.5Tg.MR1−/− mice suggested to us that
the role of MAIT cells could be revealed further if other immune
subsets were removed.
MAIT protection is more apparent in immune deﬁcient mice.
To further unmask the full potential of MAIT cells in protection,
we removed additional layers of immunity by studying the impact
of adoptively transferred MAIT cells into profoundly immuno-
deﬁcient Rag2−/−γC−/− mice in which Rag2 and the common γ
chain are deleted, leading to absence of T, B and natural killer
(NK) cells and several cytokine signaling pathways. We ﬁrst
expanded pulmonary MAIT cells by i.n. inoculation of donor
mice with S. Typhimurium BRD509, as previously described13.
Flow-sorted pulmonary MAIT cells from these mice were then
adoptively transferred into recipient Rag2−/−γC−/− mice. After
transfer, administration of anti-CD4 and anti-CD8 monoclonal
antibodies was used to further deplete any residual contaminating
conventional T cells (Fig. 6a). After adoptive transfer, MAIT cells
expanded spontaneously to generate a stable population by two
weeks (Figs. 6b and 7a).
Although anti-CD4 and anti-CD8 mAbs were administered to
deplete conventional CD4+ and CD8+ T cells, this exerted only a
minor impact on eventual MAIT cell frequencies (Fig. 7b, c).
Proportions of CD4+, CD8+ and CD4−8− MAIT cells remained
largely unchanged (Chen et al.13 and Fig. 7c). Moreover, this
temporary administration of anti-CD4 and anti-CD8 mAbs had
no impact on weight loss or survival kinetics of Legionella-infected
Rag2−/−γC−/− mice (Fig. 7d, e). Direct comparison with
conventional CD4+ or CD8+ T cells showed that MAIT cells
could protect mice from lethal challenge similarly to CD8+
Fig. 3 L. longbeachae induces long-lasting expansion of pulmonary MAIT cells. a Flow cytometry plots showing MAIT cell percentage among TCRβ+
lymphocytes in the lungs of C57BL/6 mice either uninfected or infected with 103, 104 or 105 CFU L. longbeachae for 7 days. Relative (b) and absolute (c)
numbers of MAIT cells and conventional αβ T cells 7 days post infection. Kinetics of MAIT cells during 300 days after intranasal infection with 2 × 104 CFU
L. longbeachae: absolute numbers (d), and relative percentages (e) of MR1-5-OP-RU tetramer+MAIT cells or conventional αβ-T cells in C57BL/6 and MR1
−/− mice. f Representative ﬂow cytometry plots and g summarised data from BrdU incorporation assays to detect cellular proliferation in lung and draining
lymph nodes of uninfected mice or at days 3 and 5 after intranasal infection with 104 CFU L. longbeachae. Percentages in brackets represent the proportion
of MR1-5-OP-RU tetramer+ MAIT cells with BrdU incorporation. Experiments used 4–6 (a–e) or 3 (f, g) mice per group (mean ± SEM) and were
performed twice with similar results. Mice were infected as described above and injected i.p. with 2 mg BrdU in 200 μl volume. After 2 h, mice were killed
for T-cell preparation. Cells were stained with a cocktail of antibodies and 5-OP-RU tetramers ﬁrst, then permeabilised and ﬁxed for intranuclear DNA
staining with anti-BrdU antibody. B6 C57BL/6 mice, BrdU bromodeoxyuridine, CFU colony-forming units, DPI days post infection. Statistical tests: ANOVA
followed by Dunnett’s test: **P < 0.01, ****P < 0.0001; C all comparisons with the respective uninfected (naive) groups P < 0.0001 for Dunnett’s on log-
transformed data. See also Supplementary ﬁgures 5, 6
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conventional T cells, and slightly less than CD4+ conventional
T cells in terms of both survival kinetics and bacterial load (Fig. 7f,
g). We also assessed Rag2−/− mice which lack T and B cells but
have an intact NK population. These mice recover well from
pulmonary Legionella infection (2 × 104 CFU) (Fig. 7h), indicating
a role for NK cell immunity. Thus, MAIT cells function as part of
a complex immune response, and Rag2−/−γC−/−mice constituted
an optimal recipient strain to reveal MAIT cell functions.
Strikingly, the presence of adoptively transferred MAIT cells
was sufﬁcient to rescue completely Rag2−/−γC−/− mice from
fatal infection with 103CFU L. longbeachae (Fig. 6c, Χ2 P <
0.0001) in the absence of other components of adaptive
immunity. Using a higher inoculum (104 CFU) we observed this
protection was reduced by blockade with anti-MR1 mAb, which
was associated with signiﬁcantly reduced survival (Χ2 P= 0.005)
and with increased bacterial load amongst surviving mice (t-test
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P= 0.0004), consistent with an MR1-dependent mechanism
(Fig. 6d, e).
MAIT cell protection is dependent on IFN-γ. To determine the
mechanism by which MAIT cells provide this protection we used
adoptive transfer of MAIT cells from mice with deﬁciencies in
cytotoxic capability or in pro-inﬂammatory cytokines. The pro-
tective effect of MAIT cells on both survival of Rag2−/−γC−/−
mice or on bacterial burden was not impaired in MAIT cells
lacking the cytolytic proteins perforin or granzymes A and B, nor
in MAIT cells unable to express IL-17A or TNF (Fig. 8a, b). We
observed a small increase in bacterial burden when transferred
MAIT cells were deﬁcient in GM-CSF (0.49 log-fold difference in
CFU, P= 0.026), but this was not associated with signiﬁcant
differences in survival. By contrast, protection was critically
dependent on MAIT cell-derived IFN-γ: when donor MAIT cells
were deﬁcient in IFN-γ, survival was decreased (P < 0.0001) and
there was a 2.8 log-fold increase in bacterial burden (t-test P <
0.001) amongst the small proportion (3/21) of animals which
survived till 23 DPI.In separate similar experiments, all mice
transferred with IFN-γ deﬁcient MAIT cells, succumbed within
35 days post Legionella infection.
Consistent with this protection, transferred MAIT cells
expressed relevant pro-inﬂammatory cytokines (IL-17A, IFN-γ,
GM-CSF) during L. longbeachae challenge. Adoptively trans-
ferred MAIT cells maintained an effector-memory cytokine
proﬁle in uninfected mice, similar to their corresponding 100
DPI counterparts, with the exception of GM-CSF (compare
Fig. 4b with Fig. 8d). Most strikingly, MAIT cells increased IFN-γ
expression signiﬁcantly by >5-fold from 1.7% in C57BL/6 (Fig. 4a,
b) to 9.8% (Fig. 8c, d), and GM-CSF expression increased 27-fold
(3.3% to 9.1%), whilst IL-17A remained largely unchanged (27%
to 30%).
The use of adoptive transfer of in vivo expanded MAIT cells
provides compelling evidence that MAIT cells can confer
protection against important human pathogens and demonstrates
this protection depends upon their capacity to produce IFN-γ and
to a lesser extent GM-CSF.
Discussion
Our ﬁndings show that MAIT cells are activated and proliferate
locally in response to Legionella infection, leading to enhanced
immune protection in vivo that is dependent on IFN-γ and GM-
CSF. This protection is evident earlier and of greater magnitude if
mice are ﬁrst vaccinated to expand and prime MAIT cells which are
otherwise present in small numbers in normal mice. Protection by
MAIT cells is characterised by more rapid reduction in bacterial
loads and is MR1 dependent, suggesting mediation via antigen-
speciﬁc activation. Remarkably, MAIT cell protection against
Legionella was non-redundant and even evident in immune com-
petent mice. The protective effect of MAIT cell immunity became
more evident as layers of immunity were removed in host mice,
ﬁrstly in GK1.5 mice lacking only CD4+ T cells and then in more
profoundly immundeﬁcient Rag2−/−γC−/− mice, lacking conven-
tional T cells, B cells and NK cells. This observation is important
given that studies of primary immunodeﬁciencies34 imply redun-
dancy of different lymphocyte subsets is a typical feature of
pathogen immunity especially for innate mechanisms such as NK
cells and innate lymphoid cells. Indeed, our T-cell transfer data in
Fig. 7f, g and data from Rag2−/− mice in Fig. 7h suggested clear
protective roles for CD4+, CD8+ T cells and NK cells. In the
absence of B, T and NK cells in Rag2−/−γC−/− mice, MAIT cells
were absolutely critical for survival in Legionella-infected mice,
revealing their important potential in compromised hosts. As this
mechanism is dependent on MR1, which presents small molecules
derived from riboﬂavin biosynthesis3–5, this demonstrates in vivo
the potential for control of Legionella by detection of riboﬂavin
metabolites.
The BrdU incorporation data demonstrated MAIT cell accu-
mulation at the site of infection is largely due to local activation
and proliferation. In several human studies23,24,26, a decrease in
MAIT cell numbers has been observed in the blood of patients
with infections, including tuberculosis25, and it has been hypo-
thesised that MAIT cells trafﬁc from the blood to the infected
sites. We did not observe any fall in peripheral blood frequencies
in our previous studies with Salmonella infection or
vaccination13,35. It is still possible that in some infections
inﬂammation-driven non-speciﬁc activation of MAIT cells24,26,36
could lead to MAIT cell exhaustion and premature apoptosis.
However, this speculation remains to be tested experimentally.
These observations suggest how the contribution of MAIT cells
to immune protection may be critical to survival in clinical,
naturally occurring severe infection. In essence, MAIT cells may
be the difference between life and death in knife-edge infections
where host immunity is partially compromised by comorbidities
or predisposing factors, or where patients are exposed to large
bacterial doses.
Although MAIT cells have both cytotoxic activity37 and the
ability to rapidly produce pro-inﬂammatory cytokines including
IL-17A, TNF and IFN-γ10, the protective effect of MAIT cells
against Legionella infection was not dependent on TNF or IL-
17A, but instead relied upon the capacity of MAIT cells to secrete
IFN-γ and GM-CSF. This is consistent with a study of Francisella
infection38 where GM-CSF reduces bacterial burden late in the
course of infection, although this did not translate into a sig-
niﬁcant survival difference. Nor did the protective effect depend
on the key cytotoxic effector molecules: perforin and granzymes
A/B. This is in contrast to work suggesting MAIT cell cytotoxicity
is important for control of Shigella-infected HeLa cell lines
in vitro37.
As Legionella infects inﬂammatory cells, particularly neu-
trophils and macrophages, rather than epithelia, the essential
immune function required of MAIT cells in our system is likely
the IFN-γ-stimulated enhancement of bactericidal activity within
these cells in which phagosome function has been subverted. Our
ﬁndings of IFN-γ production upon MAIT cell activation are
consistent with other reports6,10,14,37, and accord with reports of
Fig. 4 MAIT cell cytokine and transcription factor proﬁles during Legionella infection. a Representative ﬂow cytometry plots showing intracellular staining
for IL-17A, IFN-γ and GM-CSF by pulmonary TCRβ lymphocytes (non-MAIT conventional and MAIT cells) after 4 h of culture (direct ex vivo, top panel or
with PMA/ionomycin stimulation, second panel) with brefeldin A. Lymphocytes were harvested from lungs of C57BL/6 mice infected with 2 × 104 CFU L.
longbeachae for 7 days. Percentages in brackets represent the proportion of MR1-tetramer-positive MAIT cells expressing cytokine. b Percentages and
c absolute numbers of pulmonary MAIT cells producing IL-17A, IFN-γ or GM-CSF by intracellular staining, directly ex vivo from C57BL/6 mice infected for
0, 7 or >100 days with 2 × 104 CFU L. longbeachae. Data were pooled with 5–9 mice per group (mean ± SEM) from 3 independent experiments. MAIT
frequencies are compared using one-way ANOVA with post hoc Tukey’s. *P < 0.05, **P < 0.01, ***P < 0.001, ****P< 0.0001. d Representative ﬂow
cytometry plots of MAIT cells expressing T-bet and RORγt. e Average proportion of T-bet+, RORγt+, double positive (DP) and double negative (DN)
MAIT cells from uninfected or infected C57BL/6 mice at indicated date. Mean values of 5–9 mice in each group from 3 independent experiments. See also
Supplementary ﬁgure 7C, 7D for individual data points. Mice were either naive or infected similarly as in b
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a role for MAIT cell-derived IFN-γ in limiting growth of Fran-
cisella tularensis in bone marrow-derived macrophages in vitro14.
IFN-γ has also been shown to enhance bactericidal activity of
neutrophils via multiple mechanisms including enhancement of
oxidative burst, nitric oxide production, antigen presentation,
phagocytosis and upregulation of CD80/86 co-stimulation and T
cell-recruiting cytokines and chemokines39. Furthermore, T cell-
derived IFN-γ has been shown to stimulate the bactericidal
activity of monocyte-derived cells in murine L. pneumophila
infection40, and IFN-γ has been shown to be important for the
control of L. longbeachae41. Moreover, given that IFN-γ is also
critical for protection against mycobacterial disease including
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Fig. 5 MAIT cell protection in Legionella infection accelerated by MAIT cell expansion. a, b Bacterial load (CFU) in lungs of C57BL/6 or MR1−/− mice
following intranasal infection with 2 × 104CFU L. longbeachae. Dashed line represents limit of detection. a Bacterial load over the time-course of infection.
b Bacterial load at days 10 and 14 post-infection, from three independent experiments. Pooled data were compared using a Mann-Whitney test.
c Schematic for d, e: C57BL/6 or MR1−/− mice were treated with 20 μg CpG (d, e) or 20 nmol Pam2Lys (f) in combination with 76 pmol 5-OP-RU (in 50
μl) intranasally 1 month before 2 × 104 CFU L. longbeachae inoculation. d Absolute numbers of MAIT cells and conventional T cells from lungs of naive or
ligand-boosted C57BL/6 mice 30 days after administration of ligand. e Bacterial load comparison of vaccinated C57BL/6 vs MR1−/− mice. f Differences in
bacterial load in lungs of C57BL/6 or ligand-boosted C57BL/6 or MR1−/− mice apparent at 5, 7 and 10 DPI. g Bacterial load in lungs of mice lacking CD4+
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****P < 0.0001
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Mycobacterium tuberculosis (M.tb), it is likely that this early
production of MAIT cell-derived IFN-γ may be an important and
non-redundant component of protection against mycobacteria.
Indeed, in vitro MAIT cell-derived IFN-γ inhibits growth of
Bacillus Calmette-Guerin (BCG) in macrophages42, and the
MR1–MAIT cell axis has been linked to susceptibility to BCG in
mice42 and to M.tb in humans43 and mice44.
A striking feature of MAIT cell biology is the very low fre-
quencies of MAIT cells we observe in blood or lungs in naive
mice12,13, in contrast to the marked and long-lived expansion
induced by a single infection in our model. Although antigen-
naive MAIT cells have some intrinsic effector capacity45, the
delay between initial microbial exposure and peak MAIT cell
frequency may be critical in providing a window of opportunity
for a pathogen to exploit14. This notion is consistent with our
observation that MAIT cell protection can be accelerated by prior
expansion of the pulmonary MAIT cell population using intra-
nasal synthetic 5-OP-RU and an appropriate TLR agonist.
Notably, MAIT cell frequencies are low in early childhood46,
suggesting the potential to enhance the immunogenicity of
vaccines given in early life by incorporating such MAIT cell
ligands in combination with TLR stimulation, which might for
instance promote the recruitment of inﬂammatory monocyte
differentiation via MAIT cell-derived GM-CSF38.
In contrast, however, to a previous report that the protective
effect of MAIT cells is mediated by enhanced recruitment of
inﬂammatory monocytes to recruit more CD4+ T cells to the site
of infection38, in the GK1.5Tg vs GK1.5Tg.MR1−/− setting, in
which there are no CD4+ T cells present, we nonetheless
observed differences in bacterial burden in suggesting that
MAIT cells can also contribute directly to immune protection.
MAIT cells show remarkable evolutionary conservation in
several aspects: their conserved semi-invariant T-cell receptor,
their shared antigen speciﬁcity across pathogen species and their
restriction by MR1 molecules which are highly conserved across
mammals. Our ﬁndings with MAIT cell priming demonstrated
that previous immunisation not only generated a long-lasting
expansion in MAIT cell frequencies (Fig. 3e), but also modiﬁed
their cytokine proﬁle (Fig. 4), affecting the quality of their effector
functions. These effects together likely contributed to the
0 3 6 9 12 15 18 21
0
50
100
Days post infection
Pe
rc
en
t s
ur
vi
va
l
Untreated n=22
+MAIT cells n=28
0 3 6 9 12 15 18 21
0
50
100
Days post infection
Pe
rc
en
t s
ur
vi
va
l
Untreated n=19
+MAIT cells n=21
+MAIT cells/anti-MR1 n=14 
M
R
1-
5-
O
P-
RU
 te
t
TCRβ
Untreated
(without MAIT transfer)
MAIT
5.33E–3
MAIT
7.06
MAIT
transfer
i.n.103 or 104 CFU
L. longbeachea
RAG2–/–γC–/–
mice
Antibody
injections
1 week 1–2 weeks
T-cell
resting
With MAIT
transfer
+MAIT cells +MAIT cells
anti-MR1
0
2
4
6
Lo
g1
0 
CF
U 
/ l
un
g
ba
c
d e
Fig. 6 Adoptive MAIT cell transfer rescues Rag2−/−γC−/− mice from fatal Legionella infection. a Schematic of protocol: 105 pulmonary MAIT cells from
C57BL/6 mice previously infected with 106 CFU S. Typhimurium BRD509 for 7 days to expand the MAIT cell population were sorted and transferred
intravenously into Rag2−/−γC−/− mice, followed by intraperitoneal anti-CD4 and anti-CD8 antibody injection (0.1 mg each) twice within 1 week to deplete
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(7AAD−) hematopoietic (CD45.2+) cells with percentages of MAIT cells in the lungs of Rag2−/−γC−/− mice which were untreated or were recipients of
adoptively transferred MAIT cells. c Survival of Legionella-infected untreated or MAIT cell-recipient Rag2−/−γC−/− mice after 103 CFU i.n. L. longbeachae
infection. d Survival of Legionella-infected untreated or MAIT cell-recipient Rag2−/−γC−/− mice after 104 CFU i.n. L. longbeachae, with or without anti-MR1
blockade. One group received 0.25mg anti-MR1 monoclonal antibody alternate days after infection. e Pulmonary bacterial load in surviving Rag2−/−γC−/−
mice in d 23 DPI. Pooled data (mean ± SEM) from two independent experiments, each with 7–12 mice per group. See also Fig. 7
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05202-8
10 NATURE COMMUNICATIONS |  (2018) 9:3350  | DOI: 10.1038/s41467-018-05202-8 | www.nature.com/naturecommunications
0 1 2 3 4 5 6
0
1
2
3
4
5
Weeks post adoptive transfer
0 2 4 6 85 7
0
50
100
Days post infection
Pe
rc
en
t s
ur
vi
va
l
With CD4/CD8 depletion  n=7
Without CD4/CD8 depletion  n=7
M
R
1-
5-
O
P-
RU
 te
t
TCRβ
Without
CD4/8 depletion
With
CD4/8 depletion
Uninfected Infected
0
1
2
3
4
5
Lo
g1
0 
CF
U 
/ l
un
g
****
ns
0 2 4 6 85 7
110
100
90
80
70
60
Days post infection
W
ei
gh
t c
ha
ng
e 
%
With CD4/CD8 depletion
Without CD4/CD8 depletion
Non-MAIT
7.89
Non-MAIT
0.036
0 3 6 9 12 15 18 21
0
50
100
Days post infection
Pe
rc
en
t s
ur
vi
va
l
Untreated n=19
MAIT n=21
CD4 n=12
CD8 n=12
0 7 14
4
5
6
Days post infection
Lo
g1
0 
CF
U 
/ l
un
g
CD
4
CD8
Ab
so
lu
te
 M
AI
T 
ce
ll
n
u
m
be
r i
n 
lu
ng
s 
(×1
05
)
a b
dc
e
g h
f
+MAIT cells +CD4 T cells +CD8 T cells
0.15
90.7
0.20
8.96
0.45
89.2
0.084
10.3
Fig. 7 MAIT cell population expands after adoptive transfer. a Numbers of pulmonary MAIT cells increase in the lungs of recipient Rag2−/−γC−/− mice
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from 2 independent experiments. h Rag2−/− mice infected with 2 × 104 CFU L. longbeachae were capable of clearing Legionella; n= 5 mice/time point. The
experiment was performed twice with similar results
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enhanced protection observed (Fig. 5e, f). We believe this work is
the ﬁrst to demonstrate that MAIT cells form a memory pool. As
it remains debatable whether invariant NKT cells are capable of
forming a stable memory population47, it therefore enriches our
understanding of innate-like T cells, and provides a basis from
which to explore therapeutic approaches, including vaccination.
A protective effect of expanded MAIT cells could contribute to
heterologous protection afforded by neonatal BCG vaccination
against other, unrelated classes of pathogens48 and could have
implications for immunocompromised populations and in
managing infections with multiple drug-resistant bacteria. Vac-
cination with MAIT cell ligands might help resolve chronic
infections where MAIT cell frequencies may be reduced due to
other therapies11, comorbidities or activation-induced cell
death49.
Our ﬁndings deﬁne a signiﬁcant role for MAIT cells in pul-
monary host defence against a major human pathogen. We reveal
layers of immunological redundancy likely to mask the con-
tribution of MAIT cells in many situations of infectious challenge,
but suggest a critical role for MAIT cells becomes apparent in a
crisis situation—as reﬂected here in a high-infecting inoculum, or
in the face of compromised speciﬁc immunity—in which the gulf
between survival and death is ﬁnely balanced. Moreover, we
demonstrate the mechanism of this MAIT cell protection is IFN-γ
dependent and enhanced by GM-CSF. Due to the pleiotropic
roles of IFN-γ and the conservation of the riboﬂavin pathway
across many species, this mechanism is likely broadly effective
against other major human intracellular pathogens, and may
prove as relevant to the later stages of infection as to the initial,
acute phase characterised by innate immune responses counter-
ing rapid pathogen replication. We have shown this immunity
can be augmented by exposure to MR1 ligands, suggesting this
mechanism might have potential for preventive or therapeutic
beneﬁt.
Methods
In vitro activation assays. Jurkat cells expressing a MAIT TCR comprising the
TRAV1-2-TRAJ33 α-chain and TRBV6-4 β-chain (Jurkat.MAIT)3 were co-
incubated at 105 cells per well in 96-well U-bottom plates with an equal number of
class I reduced (C1R) antigen-presenting cells (APCs) expressing MR1 (C1R.MR1)
3 for 16 h in RPMI-1640 media (Gibco) in supplement and 10% foetal calf serum
(RF10) media at 37 °C, 5% CO2. Cells were stimulated for 16 h with bacterial
lystates prepared using repeated ultrasonication of bacteria in log-phase growth.
Cells were stained with anti-CD3-APC and anti-CD69-PE Abs and 7-
aminoactinomycin D (7AAD; 1:500) before ﬂow cytometric analysis. Activation of
Jurkat.MAIT cells was measured by an increase in surface CD69 expression.
For human MAIT cell assays, PBMCs were stained with anti-CD3-PECF594,
CD161-PECy7, TCRVα7.2 (TRAV1-2)-APC. Vα7.2+ cells were enriched with anti-
APC magnetic beads and the CD3+Vα7.2+CD161+ population was isolated by
ﬂow cytometry and cultured at 104 cells/well for 16 or 36 h in penicillin-free media
containing streptomycin and gentamicin with 5 × 104 THP1 cells which had been
ﬁrst infected for 3 h (CD69 assays) or 27 h (intracellular cytokine staining) with
different multiplicities of infection (MOIs) of live L. longbeachae NSW150. Control
wells contained 5-OP-RU 10 nM or L. longbeachae NSW150 at MOI 100 which
had been heat killed for 10 min at 67 °C. CD69 upregulation was measured by
surface staining for CD69-APCCy7 and 5-OP-RU loaded human MR1 tetramer-
PE. For intracellular cytokine expression of cells, brefeldin A was added for the last
16 h, and cells were ﬁxed, permeabilised (using BD Fixation/Permeabilization Kit
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(BD, Franklin Lakes, NJ) and stained with MR1 tetramer, CD3-PE CF594, Zombie
yellow, IFN-γ-FITC and TNF-Paciﬁc blue.
For murine MAIT cell assays, splenocytes (1–2 × 105) from Vα19iCα−/−MR1+.
Ly5.1 mice were prepared and co-cultured with iBMDM.MR1 cells (105) overnight
with or without lysate of L. longbeachae. iBMDM.MR1 cells were used as APCs. 5-
OP-RU was used as a positive control at ﬁnal concentration of 1 nM. Anti-mouse
MR1 mAb 8F2.F9 or its IgG1 isotype control (in-house) were added to examine
MR1-speciﬁc antigen presentation. CD69 and CD25 upregulation or the
percentage of CD69/CD25-expressing cells were measured by ﬂow cytometry for
MAIT cell activation after staining together with other T-cell antibodies.
Generation of cell lines. THP1.MR1− cell lines were generated by targeted
deletion of MR1 using Lentiviral CRISPRv2 which was a gift from Feng Zhang
(Addgene plasmid # 52961)50. The plasmid was digested with BsmB1 (Fermentas),
dephosphorylated and puriﬁed using gel electrophoresis and the Ultraclean DNA
isolation kit (MO Bio Laboratories, Carlsbad CA). Short guide RNAs
(ACCTCTCATCATTGTGTTAA) were ligated and the reaction product used to
transform Stbl3 Escherichia coli. DNA was puriﬁed from transformed colonies
(QIAprep spin miniprep) and used to transfect HEK293T (ATCC CRL-3216,
ATCC, Manassas, VA) cells with LentiviralCRISPRv2 vector and packaging vec-
tors. Supernatants were used to transduce parent THP1 cells (ATCC TIB-202,
ATCC) and cells were selected using puromycin resistance and single-cell sorting
using anti-MR1 antibody (8F2.F9) after upregulation of MR1 using acetyl-6-FP.
MR1 knockouts were then veriﬁed using surface staining and western blotting.
C1R.hMR1, THP.hMR1+ and iBMDM.MR1 cell lines were created via
retroviral transduction as described previously51, using human or murine MR1
cloned in pMIG plasmids. BMDMs were commercially available (EMG014,
Kerafast, Boston, MA). At the end of the transduction, MR1 expression of the
corresponding cell lines was analysed by staining with anti-MR1 antibodies (26.5
for hMR1 and 8F2 for mMR1) by ﬂuorescence-activated cell sorting (FACS). In
these transduced cell lines, green ﬂuorescent protein (GFP) expression levels
correlated well with surface expression of MR1. Cells with high expression of both
GFP and MR1 were enriched by FACS and subsequently cloned by single-cell
sorting using ﬂow cytometry. The function of tranduced MR1 were conﬁrmed by
in vitro cellular activation assays using Jurkat.MAIT as previously described13.
Immunoﬂuorescence microscopy. The 8 μm sections of cryopreserved, unﬁxed
human and murine lung tissue were submerged into ice-cold acetone for 10 min,
air dried and then re-hydrated in PBS for 10 min. Endogenous biotin block was
performed using Biotin/Avidin blocking kit (Thermo Fisher, Waltham MA)
according to the manufacturer’s instructions. Serum-free protein block (DAKO,
Carpinteria, CA) was applied for 15 min, followed by 30 min of blocking with 10%
normal donkey serum. Sections were subsequently blocked with Murine MR1-6-FP
tetramer (nil conjugate) for 1 h at room temperature. Murine MR1-5-OP-RU
tetramer-PE (25 μg ml−1 in 2% bovine serum albumin/PBS) was applied for 1 h at
room temperature in the dark, sections washed with PBS, ﬁxed with 1% paraf-
ormaldehyde for 10 min, washed again and stained with a cocktail containing
polyclonal rabbit anti-Legionella antibody (gift from Dr Hayley Newton, Depart-
ment of Microbiology and Immunology, University of Melbourne) and Goat anti-
PE (KPL). After 1 h, sections were washed and stained with Donkey anti-Goat-
Alexa Fluor 568 (Life Technologies), Donkey-anti-Rabbit-DyLight 680 (Life
Technologies) and Alexa Fluor 647-conjugated Rat anti-mouse TCRβ (Biolegend).
Nuclei were counterstained with Hoechst 33342 (Life Technologies).
Following rehydration, the unﬁxed cryopreserved 8 μm sections of human lung
were blocked with serum-free block and stained with puriﬁed anti-Vα7.2 TCR
mAb clone 3C10 (Biolegend), rat anti-human CD3 mAb (BioRad) and polyclonal
rabbit anti-Legionella antibody. After 1 h at room temperature, sections were
washed and stained with a cocktail of secondary antibodies containing goat anti-
mouse Alexa Fluor 568, goat anti-rat Alexa Fluor 488 and goat anti-rabbit Alexa
Fluor 647, all from Life Technologies. Nuclei were counterstained with Hoechst
33342 (Life Technologies).
Sections were mounted with Prolong Gold mounting medium (Life
Technologies). Image acquisition was performed on Zeiss LSM 710 confocal
microscope using Zen software (Zeiss, Oberkochen, Germany) The resultant
images were further analysed using FIJI Image J software52 (UW-Madison).
Mouse models. Mice were bred and housed in the Biological Research Facility of
the Peter Doherty Institute (Melbourne, Victoria, Australia). MR1−/− and Vα19iCα
−/−MR1+/+ (Ly5.1) mice were generated by breeding Vα19iCα−/−MR1−/− mice53
(from Susan Gilﬁllan, Washington University, St Louis School of Medicine, St Louis,
MO) with C57BL/6, Ly5.1 and TCRα−/− mice separately and inter-crossing of F1
mice. The genotype was determined by tail DNA PCR at the MR1 locus or ﬂow
cytometry after staining with relevant antibodies as previously described13. Gran-
zyme A−/−, B−/− or double knockout (KO; A−/−, B−/−) and Perforin−/− mice
were provided by Joe Trapani (Peter MacCallum Cancer Centre, Melbourne). GK1.5
mice were crossed onto the MR1−/− background to generate GK1.5.MR1−/− mice
which lack CD4+ cells and MAIT cells. Speciﬁc pathogen-free, co-housed male mice
aged 6–12 weeks were used in experiments, after approval by the University of
Melbourne Animal Ethics Committee (1513661).
Intranasal infection. The i.n. inoculation with L. longbeachae or antigens (76 pmol
5-OP-RU) and TLR agonist (either 20 μg CpG or 20 nmol Pam2Cys) in 50 μl per
nare was performed on isoﬂuorane-anaesthetised mice. For blocking experiments,
mice were given 250 μg anti-MR1 (26.5 or 8F2.F9)21,54 or isotype control mAbs in
200 μl PBS, once intraperitoneally (i.p.) 1 day prior to inoculation and three times
(d1, d3, d5) post inoculation. Mice were killed by CO2 asphyxia, perfused through
the heart with 10 ml cold RPMI and lungs were taken.
To prepare single-cell suspensions, lungs were ﬁnely chopped with a scalpel
blade and treated with 3 mgml−1 collagenase III (Worthington, Lakewood, NJ), 5
μg ml−1 DNAse and 2% foetal calf serum in RPMI for 90 min at 37 °C with gentle
shaking. Cells were then ﬁltered (70 μm) and washed with PBS/2% foetal calf
serum. Red blood cells were lysed with hypotonic buffer TAC (Tris-based amino
chloride) for 5 min at 37 °C. Approximately 1.5 × 106 cells were ﬁltered (40 μm)
and used for ﬂow cytometric analysis.
Bacterial counts in infected lungs. Bacterial colonisation was determined by
counting CFU obtained from plating homogenised lungs in duplicate from infected
mice (×5 per group) on buffered charcoal yeast extract agar containing 30 μg ml−1
streptomycin and colonies counted after 4 days at 37 °C under aerobic conditions.
Adoptive transfer. As MAIT cell frequencies are low in naive C57BL/6 mice, prior
to adoptive transfer experiments, MAIT cell populations were expanded by i.n.
infection with 106 CFU S. Typhimurium BRD509 in 50 μl PBS for 7 days as
previously described13. After 7 days, mice were killed, single-cell suspensions
prepared and live CD3+CD45+MR1-5-OP-RU tetramer+ cells sorted using BD
FACS Aria III. Next, 105 MAIT cells were injected into the tail veins of recipient
mice which then received 0.1 mg each of anti-CD4 (GK1.5) and anti-CD8 (53.762)
intraperitoneally on days 2 and 5 or 6 to control residual conventional T cells. Mice
were rested for 2 weeks post transfer to allow full expansion of the MAIT cell
population prior to subsequent infectious challenge. Mice were weighed daily and
assessed for visual signs of clinical disease, including inactivity, rufﬂed fur, laboured
breathing and huddling behaviour. Animals that had lost ≥20% of their original
body weight and/or displayed evidence of pneumonia were killed.
Statistical analysis. Statistical tests were performed using the Prism GraphPad
software (version 7.0 La Jolla, CA). Comparisons between groups were performed
using Student’s t-tests, ANOVA tests or Mann–Whitney tests as appropriate unless
otherwise stated. Survival curves were compared using the Gehan–Breslow–Wilcoxon
method for multiple groups.
Reagents. Human PBMCs were obtained from the Australian Red Cross Blood
Service (ARCBS) after approval from the University of Melbourne Human
Research Ethics Committee (1239046.2). Healthy human lung explant tissue was
obtained via the Alfred Lung Biobank program and ARCBS from organs not
suitable for donation after approval from the Blood Service HREC (2014#14) and
University of Melbourne Human Research Ethics Committee (1545566.1).
Compounds, immunogens and tetramers. 5-OP-RU was prepared as described
previously18. CpG1688 (sequence: T*C*C*A*T*G*A*C*G*T*T*C*C*T*-
G*A*T*G*C*T (*phosphorothioate linkage) nonmethylated cytosine-guanosine
oligonucleotide was purchased from Geneworks (Thebarton, Australia). Murine
and human MR1 and β2-Microglobulin genes were expressed in E. coli inclusion
bodies, refolded and puriﬁed as described previously55. MR1-5-OP-RU and MR1-
6-FP tetramers were generated as described previously4 and used in 1:200 dilution.
Bacterial strains. Cultures of Legionella pneumophila JR32 and Legionella long-
beachae NSW150 were grown at 37 °C in buffered yeast extract (BYE) broth
supplemented with 30–50 μg ml−1 streptomycin for 16 h to log-phase (OD600
0.2–0.6) with shaking at 180 rpm. For the infecting inoculum, bacteria were re-
inoculated in prewarmed medium for a further 2–4 h culture (OD600 0.2–0.6) with
the estimation that 1 OD600= 5 × 108 ml−1, sufﬁcient bacteria were washed and
diluted in PBS with 2% BYE for i.n. delivery to mice. A sample of inoculum was
plated onto BYCE with streptomycin for veriﬁcation of bacterial concentration by
counting colony-forming units.
For infection of adoptive transfer donor mice with S. Typhimurium BRD509
cultures were prepared as previously described13.
Antibodies and ﬂow cytometry. Antibodies against murine CD4 (1:200 GK1.5,
APCCy7), CD19 (1:200, 1D3, PerCP-Cy 5.5), CD45.2 (1:200, 104, FITC), IFN-γ
(1:400, XMG1.2, PECy7), Ly6G (1:200, IA8, PECy7), TCRβ (1:200, H57-597, APC
or PE), TNF (1:200, MP6-XT22, PE), GM-CSF (1:200, MP1-22E9, PE) and IL-17A
(1:400, TC11-18H10, PE) were purchased from BD (Franklin Lakes, NJ). Anti-
bodies against CD8a (1:800, 53-6.7, PE), PLZF (1:200, Mags.21F7, PE), RORγt
(1:200, B2D, APC), T-bet (1:200, 4B10, PECy7) and MHCII (1:400, M5/114.15.2,
AF700) were purchased from eBioscience (San Diego, CA). Antibodies against
CD19 (1:200, 6D5, BV510), F4/80 (1:200, BM8, APC), CD11b (1:200, M1/70,
FITC), CD11c (1:400, N418, BV786), CD31 (1:200, PCAM, MEC13.3,
PerCPCy5.5), CD62L (1:200, Mel-14, FITC), CD64 (1:200, X54-5/71, BV711),
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CD146 (1:200, ME-9F1, PerCPCy5.5) and CD326 (1:200, G8.8, EpCAM, APCCy7)
were purchased from Biolegend (San Diego, CA). Blocking Ab (20 μg ml−1, 26.5,
8F2.F9) and isotype controls (20 μg ml−1, 3E12, 8A5) were prepared in-house. To
block non-speciﬁc staining, cells were incubated with MR1-6-FP tetramer (nil
conjugate, 1:100) and anti-Fc receptor (1:200, 2.4G2) for 15 min at room tem-
perature and then incubated at room temperature with Ab/tetramer cocktails in
PBS/2% foetal calf serum. 7AAD (5 μl per sample) was added for the last 10 min.
Antibodies against human CD3 (1:100, UCHT1, PE-AlexaFluor594), TCRVα7.2
(1:50, 3C10, APC), CD161 (1:100, HP-3G10, PECy7), TNF (1:50, Mab11, Paciﬁc
Blue) and viability dye (1:100, Zombie Yellow) were purchased from Biolegend.
Antibodies against IFN-γ (1:50, 25725.11, FITC) and CD69 (1:50, FN50, PE) were
purchased from BD, and anti-CD3 (1:100, UCHT1, APC) from eBioscience.
Cells were ﬁxed with 1% paraformaldehyde prior to analysis on LSRII or LSR
Fortessa or Canto II (BD Biosciences) ﬂow cytometers. For intracellular cytokine
staining Golgi plug (BD Biosciences) was used during all processing steps. Cells
stimulated with PMA (phorbol 12-myristate 13-acetate)/ionomycin (20 ng ml−1
and 1 μg ml−1, respectively) for 3 h at 37 °C were included as positive controls.
Surface staining was performed at 37 °C, and cells were stained for intracellular
cytokines using the BD Fixation/Permeabilization Kit (BD Biosciences) or
transcription factors using the transcription buffer staining set (eBioscience)
according to the manufacturers’ instructions. Flow cytometric data analysis was
performed with FlowJo10 software (Ashland, OR).
BrdU incorporation assay. The assay was performed with the commercial BrdU
In-Situ Kit (BD Biosciences) according to the manufacturer’s instruction. Brieﬂy,
mice were infected at different time points for synchronous assays on a single day.
BrdU (2 mg in 200 μl per mouse) was injected i.p. After 2 h, mice were killed for
single-cell preparation from lungs and draining lymph nodes. Cells were stained
with a cocktail of antibodies and MR1-5-OP-RU tetramers ﬁrst, then ﬁxed and
permeabilised for intranuclear DNA staining with anti-BrdU antibody and other
antibodies, as detailed above.
Data availability. Data supporting the ﬁndings of this study are available within
the paper and its supplementary information ﬁles, or are available from the authors
upon request.
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